Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome

Kidney International

Volumn 55, Issue 3, 1999, Pages 1063-1071

  Webb, Nicholas J A ^a   Watson, Carolyn J ^b   Roberts, Ian S D ^b   Bottomley, Martyn J ^b   Jones, Caroline A ^b   Lewis, Malcolm A ^b   Postlethwaite, Robert J ^b   Brenchley, Paul E C ^b  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Childhood nephrotic syndrome; Edema; Proteinuria; Vascular endothelial growth factor; VPF

Indexed keywords

VASCULOTROPIN;

ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DNA DETERMINATION; FEMALE; HUMAN; MALE; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECURRENT DISEASE;

EID: 0032987256     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.0550031063.x     Document Type: Article

References (37)

1. Sewell RF, Short CD: Minimal change nephropathy: How does the immune system affect the glomerulus. Nephrol Dial Transplant 8:108-112, 1993
2. Miles AA, Miles EM: Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118:228-257, 1952
3. Boulton Jones J, Simpson S: Immunological studies of minimal change nephropathy. Br Med J 1:291-292, 1980
4. Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T: Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect on its production in minimal change nephrotic syndrome. Nephron 41:157-160, 1985
5. Tomizawa S, Nagasawa N, Maruyama K, Shimabukuro N, Arai H, Kuroume T: Release of vascular permeability factor in minimal change nephrotic syndrome is related to CD4+ lymphocytes. Nephron 56:341-342, 1990
6. Boulton Jones J, Jones I, Dore B, McLay A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 20:72-77, 1983
7. Maruyama K, Tomizawa S, Shimabukuro N, Fukada T, Joshita T, Kuroume T: Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries. Nephron 51:73-76, 1989
8. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-460, 1991
9. Bakker WW, Van Lujik WHJ, Hené RJ, Desmit EM, Van Der Hem GK, Vos JT: Loss of glomerular polyanion in vitro induced by mononuclear blood cells from patients with minimal change nephrotic syndrome. Am J Nephrol 6:101-106, 1986
10. Bakker WW, Beukhof JR, Van Lujik WHJ, Van Der Hem GK: Vascular permeability increasing factor in IgA nephropathy. Clin Nephrol 18:165-167, 1982
11. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311-7315, 1989
12. Senger DR, Galli SS, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985, 1983
13. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA: Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632, 1990
14. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992
15. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992
16. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379, 1995
17. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW: Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 27:163-173, 1998
18. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3:211-220, 1992
19. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:240-250, 1995
20. Iijima K, Yoshikawa N, Connolly DT, Nakamura H: Human mesangial cells and peripheral blood mononuclear cells produce vascular endothelial growth factor. Kidney Int 44:959-966, 1993
21. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
22. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341-346, 1994
23. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor - A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156, 1994
24. Ferrara N: Vascular endothelial growth factor: The trigger for neovascularization in the eye. Lab Invest 72:615-618, 1995
25. Adamis AP, Miller JW, Bernal MT, Damico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450, 1994
26. Neulen J, Yan ZP, Raczek S, Weindel K, Keck C, Weich HA, Marme D, Breckwoldt M: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80:1967-1971, 1995
27. Webb NJA, Bottomley MJ, Watson CJ, Brenchley PEC: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 94:395-404, 1998
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
29. Webb NJA, Myers CR, Watson CJ, Bottomley MJ, Brenchley PEC: Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10:254-257, 1998
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
31. Ladoux A, Frelin C: Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195:1005-1010, 1993
32. Pe'er J, Shweiki D, Itin A, Hemo I, Nessin H, Keshet E: Hypoxiainduced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularising ocular diseases. Lab Invest 72:638-645, 1995
33. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262, 1993
34. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W: Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947-959, 1998
35. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G: Hypotensive activity of fibroblast growth factor. Science 254:1208-1210, 1991
36. Van Der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM: Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95:1030-1037, 1997
37. Lopez JJ, Laham RJ, Carrozza JP, Tofukji M, Selke FW, Bunting S, Simons M: Haemodynamic effects of intracoronary VEGF delivery: Evidence of tachyphylaxis and NO dependence of response. Am J Physiol 273:H1317-H1323, 1997